Talphera (NASDAQ:TLPH) Rating Increased to Hold at Wall Street Zen

Posted by on Aug 9th, 2026

Wall Street Zen upgraded shares of Talphera (NASDAQ:TLPH – Free Report) to a hold rating in a research report sent to investors on Saturday.

A number of other research analysts have also weighed in on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Talphera in a report on Friday, July 17th. Zacks Research raised Talphera to a “hold” rating in a report on Monday, June 8th. Westpark Capital initiated coverage on shares of Talphera in a research report on Thursday, April 30th. They set a “buy” rating and a $3.00 price objective for the company. Finally, HC Wainwright assumed coverage on shares of Talphera in a report on Friday, June 5th. They issued a “buy” rating and a $3.00 price objective on the stock. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $3.00.

View Our Latest Stock Analysis on Talphera

Talphera Stock Performance

Talphera stock opened at $1.43 on Friday. Talphera has a 52 week low of $0.39 and a 52 week high of $1.57. The stock has a market capitalization of $74.22 million, a P/E ratio of -4.61 and a beta of 0.69. The stock has a 50-day simple moving average of $1.14 and a 200 day simple moving average of $0.95.

Talphera (NASDAQ:TLPH – Get Free Report) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.03. Research analysts forecast that Talphera will post -0.26 earnings per share for the current year.

Hedge Funds Weigh In On Talphera

Large investors have recently made changes to their positions in the company. Group One Trading LLC lifted its holdings in Talphera by 3,224.0% during the 3rd quarter. Group One Trading LLC now owns 30,415 shares of the company’s stock worth $27,000 after purchasing an additional 29,500 shares during the last quarter. Virtu Financial LLC bought a new stake in Talphera in the 3rd quarter valued at $29,000. Mariner LLC grew its holdings in Talphera by 132.0% in the 4th quarter. Mariner LLC now owns 58,000 shares of the company’s stock valued at $66,000 after buying an additional 33,000 shares in the last quarter. Persistent Asset Partners Ltd acquired a new position in Talphera in the 4th quarter valued at $42,000. Finally, Dauntless Investment Group LLC bought a new position in Talphera during the 3rd quarter worth $89,000. Institutional investors own 37.67% of the company’s stock.

Talphera Company Profile

(Get Free Report)

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.

Further Reading

Receive News & Ratings for Talphera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talphera and related companies with MarketBeat.com's FREE daily email newsletter.